Skip to content

Clinical trials

Phase 1/2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 1/2 Country / region: China Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20231
20244
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Not yet recruiting1
Suspended1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing GoBroad Hospital3
Beijing Biotech1
Beijing Tongren Hospital1
Essen Biotech1
Guangzhou Bio-gene Technology Co., Ltd1
Peking University People's Hospital1
PersonGen BioTherapeutics (Suzhou) Co., Ltd.1
Shenzhen Geno-Immune Medical Institute1
SymBio Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma11
Lymphoma, T-Cell4
Leukemia, Myeloid, Acute3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Immunoblastic Lymphadenopathy2
Leukemia, Prolymphocytic, T-Cell2
Recurrence2
Blastic Plasmacytoid Dendritic Cell Neoplasm1
Burkitt Lymphoma1
Enteropathy-Associated T-Cell Lymphoma1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.